StockUnited StatesNasdaqGS

PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

24.44USD

-2.4800 (-9.21%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 24.44

P/E—

Dvd Ind Yld0.0%

P/B2.88

P/S20,399.7

Curr EV/T12M EBITDA-11.5

Mkt Cap (USD)3.0B

Curr EV (USD)1.9B

Per Share Data

EPS T12M-9.51

DPS—

Bk Val Per Sh8.48

Rev/Sh0.02

Cash/Sh9.07

Curr Shares Out122.0M

FCF/Sh—

Cash Flow Analysis

P/CF-27.1

Curr P/FCF—

CF/NI0.7

Dvd P/O—

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales—

Eff Interest Rate—

Growth Potential

Dil EPS 1Y Gr—

Cap 1Y Gr-33.6%

BPS 1Y Gr—

R&D To Sales—

Retention Rate—

Rev 1Y Gr—

FCF 1Y Gr—

Assets 1Y Gr—

Profitability

EBITDA-0.2B

EBIT—

Operating Margin-34382.4%

Pretax Margin—

Net Margin0.0%

ROA-14.5%

ROE-54.6%

ROC—

Asset Turnover—

Structure

Current Ratio17.91

Quick Ratio17.83

Debt/Assets0.5%

Debt/Com Eq0.6%

Net Debt/EBITDA6.39

Tot Debt/Capital0.6%

Gross Margin0.0%

EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.